Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.23.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
IPO
Ratchet
DGD
THIO
Common Stock
Common Stock
THIO Merger Agreement
Common Stock
IPO
Common Stock
Ratchet
Additional Paid-In Capital
Additional Paid-In Capital
THIO Merger Agreement
Additional Paid-In Capital
IPO
Additional Paid-In Capital
Ratchet
Additional Paid-In Capital
DGD
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Subscription Receivable
Total MAIA Equity
Total MAIA Equity
THIO Merger Agreement
Total MAIA Equity
DGD
Noncontrolling Interest
Noncontrolling Interest
THIO Merger Agreement
Noncontrolling Interest
DGD
Noncontrolling Interest
THIO
Balance at Dec. 31, 2020 $ (1,616,300)         $ 443       $ 12,599,585         $ (15,934,113)   $ (2,002) $ (3,336,087)     $ 1,719,787      
Balance, Shares at Dec. 31, 2020           4,433,644                                    
Issuance of common shares upon exercise of stock options 9,000         $ 1       8,999               9,000            
Issuance of common shares upon exercise of stock options, Shares           5,000                                    
Issuance of common shares upon exercise of warrants 529,425         $ 28       529,397               529,425            
Issuance of common shares upon exercise of warrants, Shares           283,616                                    
Issuance of restricted common shares 27,500         $ 2 $ 70     27,498 $ (70)             27,500            
Issuance of restricted common shares, Shares           15,278 700,000                                  
Cancellation of restricted common shares (1)         $ (1)                       (1)            
Cancellation of restricted common shares, Shares           (5,557)                                    
Stock-based compensation expense 2,428,935     $ 161,460 $ 104,999         2,428,935               2,428,935         $ 161,460 $ 104,999
Issuance of stock options to satisfy accrued bonus 786,531                 786,531               786,531            
Issuance of stock options to satisfy deferred compensation 285,418                 285,418               285,418            
Issuance of common shares upon conversion of convertible notes 11,001,274         $ 138       11,001,136               11,001,274            
Issuance of common shares upon conversion of convertible notes, Shares           1,375,228                                    
Issuance of common shares upon conversion of SAFE 25,000                 25,000               25,000            
Issuance of common shares upon conversion of SAFE, Shares           5,208                                    
Issuance of common shares in connection with equity financing 5,860,503         $ 77       6,180,426             (320,000) 5,860,503            
Issuance of common shares in connection with equity financing, Shares           772,563                                    
Receipt of stock subscription receivable 322,002                               $ 322,002 322,002            
Transaction costs incurred in connection with Equity Financing (118,332)                 (118,332)               (118,332)            
Reclassification of warrant liability to equity 1,952,000                 1,952,000               1,952,000            
Dissolution of firm                     $ 813,805     $ 1,098,110         $ 813,805 $ 1,098,110   $ (813,805) $ (1,098,110)  
Net loss (12,578,211)                           (12,503,880)     (12,503,880)     $ (74,331)      
Balance at Dec. 31, 2021 9,181,203         $ 758       37,618,438         (28,437,993)     $ 9,181,203            
Balance, Shares at Dec. 31, 2021           7,584,980                                    
Issuance of common shares upon exercise of stock options $ 84,000         $ 5       83,995                            
Issuance of common shares upon exercise of stock options, Shares 46,500         46,500                                    
Issuance of common shares upon exercise of warrants $ 385,400         $ 53       385,347                            
Issuance of common shares upon exercise of warrants, Shares           529,712                                    
Stock-based compensation expense 2,319,427                 2,319,427                            
Issuance of common shares in connection with equity financing 2,473,560         $ 28       2,473,532                            
Issuance of common shares in connection with equity financing, Shares           274,840                                    
Issuance of common shares   $ 8,750,095 $ 1,099,360         $ 230 $ 22     $ 8,749,865 $ 1,099,338                      
Issuance of common shares, Shares               2,300,000 219,872                              
Modification of warrant in equity 450,578                 450,578                            
Deemed dividend on modification of warrant (450,578)                 (450,578)                            
Foreign currency translation adjustment (15,973)                             $ (15,973)                
Net loss (15,769,279)                           (15,769,279)                  
Balance at Dec. 31, 2022 $ 8,507,793         $ 1,096       $ 52,729,942         $ (44,207,272) $ (15,973)                
Balance, Shares at Dec. 31, 2022           10,955,904